ESTRO 2025 - Abstract Book

S439

Clinical - Breast

ESTRO 2025

Conclusion: This study introduces a novel method of defining OAR dose constraints using "typical maximum limits" derived from national cohort data. These limits have now been implemented as part of the DBCG guidelines across all Danish centers, ensuring consistent standards in breast cancer radiotherapy planning. Additionally, the guidelines are